CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL")
Clinical trial NCT01552369 · COMPLETED
Trial details
- NCT number
- NCT01552369
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-29
- Primary completion
- 2018-06-22
- Enrollment
- 205
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.